Lymphatic transport of recombinant human tumor necrosis factor in rats.
- 1 January 1988
- journal article
- research article
- Published by Pharmaceutical Society of Japan in Journal of Pharmacobio-Dynamics
- Vol. 11 (10) , 700-706
- https://doi.org/10.1248/bpb1978.11.700
Abstract
The lymphatic transport of recombinant human tumor necrosis factor (rHU-TNF) was investigated after its administration via various routes in anesthetized rats. After intravenous (i.v.) administration, the level of rHu-TNF in the lymph reached a peak at 2 h, and thereafter decreased exponentially in a pattern similar to that of the elimination from plasma. Intramuscular (i.m.) and subcutaneous (s.c.) administration resulted in low levels of rHu-TNF both in the plasma and in the lymph. On the other hand, intraperitoneal (i.p.), intra-stomach wall (s.w.) and intra-gut wall (g.w.) administrations gave high lymph levels of rHu-TNF. AfFter the s.w., g.w. and i.p. administrations, the ratios of rHu-TNF recovered from the thoracic duct to the cumulative amount estimated from the rHu-TNF concentration in plasma were about 25, 32 and 8 times higher than in the case of i.v. administration, respectively. These results suggest that the routes of local administration of rHu-TNF such as s.w., g.w. and i.p. may be highly effective for the treatment of lymphatic metastasis of cancer.This publication has 11 references indexed in Scilit:
- PHASE-I STUDY OF RECOMBINANT TUMOR-NECROSIS-FACTOR IN CANCER-PATIENTS1987
- Anticancer effects of arterial administration of the anticancer agent SMANCS with lipiodol on metastatic lymph nodesCancer, 1987
- Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo.The Journal of Immunology, 1987
- Studies on tumor necrosis factor (TNF)—I. Pharmacokinetics of human recombinant TNF in rabbits and monkeys after intravenous administrationGeneral Pharmacology: The Vascular System, 1987
- PRECLINICAL APPROACHES TO THE TREATMENT OF METASTATIC DISEASE - THERAPEUTIC PROPERTIES OF RH TNF, RM IFN-GAMMA, AND RH IL-21987
- Recombinant human tumor necrosis factor — II. Antitumor effect on murine and human tumors transplanted in miceInternational Journal of Immunopharmacology, 1986
- Recombinant human tumor necrosis factor — I. Cytotoxic activity in vitroInternational Journal of Immunopharmacology, 1986
- Pharmacokinetics of Murine Tumor Necrosis FactorImmunopharmacology and Immunotoxicology, 1986
- Efficient production of human tumour necrosis factor in Escherichia coliJournal of Biotechnology, 1985
- Molecular weight dependence of permselectivity to rat small intestinal blood-lymph barrier for exogenous macromolecules absorbed from lumen.Journal of Pharmacobio-Dynamics, 1984